Chlordane
|
CAS
57-74-9
|
C10H6Cl8
|
RTECS
PB9800000
|
Synonyms & Trade Names
Chlordan; Chlordano; 1,2,4,5,6,7,8,8-Octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane
|
DOT ID & Guide
2762 / 131
|
Exposure
Limits
|
NIOSH REL: Ca TWA 0.5 mg/m3 [skin] See Appendix A
|
|
OSHA PEL: TWA 0.5 mg/m3 [skin]
|
IDLH
Ca [100 mg/m3]
See: 57749
|
Conversion
|
Physical Description
Amber-colored, viscous liquid with a pungent, chlorine-like odor. [insecticide]
|
MW: 409.8
|
BP: Decomposes
|
FRZ: 217-228°F
|
Sol: 0.0001%
|
VP: 0.00001 mmHg
|
IP: ?
|
|
Sp.Gr(77°F): 1.6
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Liquid, but may be utilized in flammable solutions.
|
Incompatibilities & Reactivities
Strong oxidizers, alkaline reagents
|
Measurement Methods
NIOSH 5510; OSHA 67
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Blurred vision; confusion; ataxia, delirium; cough; abdominal pain, nausea, vomiting, diarrhea; irritability, tremor, convulsions; anuria; in animals: lung, liver, kidney damage; [potential occupational carcinogen]
|
Target Organs
central nervous system, eyes, lungs, liver, kidneys
Cancer Site
[in animals: liver cancer]
|
|
See also: INTRODUCTION
See ICSC CARD: 0740 See MEDICAL TESTS: 0042
|
